Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop

Peter Kahrilas*, Foteini Anastasiou, Albert J. Bredenoord, Hashem B. El Serag, Joachim Labenz, Juan Mendive, Edoardo V. Savarino, Daniel Sifrim, Mihaela Udrescu, Rena Yadlapati, A. Pali Hungin

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Background: Despite deprescribing initiatives to curb overutilization of proton pump inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge. Summary: An international group of primary care doctors and gastroenterologists examined the literature surrounding PPI use and use-reduction to clarify: (i) what constitutes rational PPI prescribing; (ii) when and in whom PPI use-reduction should be attempted; and (iii) what strategies to use when attempting PPI use-reduction. Key Messages: Before starting a PPI for reflux-like symptoms, patients should be educated on potential causes and alternative approaches including dietary and lifestyle modification, weight loss, and relaxation strategies. When commencing a PPI, patients should understand the reason for treatment, planned duration, and review date. PPI use at hospital discharge should not be continued without a recognized indication for long-term treatment. Long-term PPI therapy should be reviewed at least annually. PPI use-reduction should be based on the lack of a rational indication for long-term PPI use, not concern for PPI-associated adverse events. PPI use-reduction strategies involving switching to on-demand PPI or dose tapering, with rescue therapy for rebound symptoms, are more likely to succeed than abrupt cessation.

Original languageEnglish (US)
Pages (from-to)211-220
Number of pages10
JournalDigestive Diseases
Volume42
Issue number3
DOIs
StatePublished - Mar 21 2024

Funding

This work is based on workshops that were funded by Reckitt Benckiser Healthcare Ltd. Editorial assistance was provided by Lumanity, UK, and funded by Reckitt Benckiser Healthcare Ltd.

Keywords

  • Gastroesophageal reflux disease
  • Oesophagus
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop'. Together they form a unique fingerprint.

Cite this